Prestige Wealth Management Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-159
| Closed | -$18.4K | – | 1081 |
|
|
2023
Q3 | $18.4K | Hold |
159
| – | – | ﹤0.01% | 339 |
|
|
2023
Q2 | $16.4K | Hold |
159
| – | – | ﹤0.01% | 383 |
|
|
2023
Q1 | $17.4K | Sell |
159
-43
| -21% | -$4.69K | ﹤0.01% | 353 |
|
|
2022
Q4 | $23K | Sell |
202
-107
| -35% | -$12.2K | 0.01% | 336 |
|
|
2022
Q3 | $19K | Buy |
309
+70
| +29% | +$4.3K | 0.01% | 331 |
|
|
2022
Q2 | $19K | Buy |
239
+36
| +18% | +$2.86K | 0.01% | 341 |
|
|
2022
Q1 | $22K | Sell |
203
-14
| -6% | -$1.52K | 0.01% | 335 |
|
|
2021
Q4 | $24K | Sell |
217
-63
| -23% | -$6.97K | 0.01% | 356 |
|
|
2021
Q3 | $30K | Sell |
280
-99
| -26% | -$10.6K | 0.01% | 314 |
|
|
2021
Q2 | $35K | Buy |
379
+79
| +26% | +$7.3K | 0.01% | 280 |
|
|
2021
Q1 | $28K | Hold |
300
| – | – | 0.01% | 310 |
|
|
2020
Q4 | $22K | Hold |
300
| – | – | 0.01% | 344 |
|
|
2020
Q3 | $23K | Hold |
300
| – | – | 0.01% | 327 |
|
|
2020
Q2 | $17K | Hold |
300
| – | – | 0.01% | 359 |
|
|
2020
Q1 | $9K | Buy |
300
+100
| +50% | +$3K | ﹤0.01% | 406 |
|
|
2019
Q4 | $7K | Hold |
200
| – | – | ﹤0.01% | 396 |
|
|
2019
Q3 | $5K | Hold |
200
| – | – | ﹤0.01% | 427 |
|
|
2019
Q2 | $5K | Buy |
+200
| New | +$5K | ﹤0.01% | 406 |
|